Related Experiment Video
Updated: Mar 23, 2026

11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
11.5K
An unusual case of cytotoxic peripheral T-cell lymphoma
Casey Wang1, Nicole Reusser2, Megan Shelton2
1Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
JAAD Case Reports
|April 7, 2016
Abstract
No abstract available in PubMed .
Keywords:
CD4/CD8 DN, CD4/CD8 double negativeCD4/CD8 double negativeCD56CTCL, cutaneous T-cell lymphomaEBER, Ebstein-Barr virus-encoded small RNAsNK, natural killerPCGD-TCL, primary cutaneous gamma-delta T-cell lymphomaPET/CT, positron emission tomography/computed tomographyPTCL, peripheral T-cell lymphomaSPCTL, subcutaneous panniculitic cutaneous T-cell lymphomaTCR, T-cell receptorcutaneous T-cell lymphomadrug-inducedhydroxychloroquineα/β T-cell lymphomaRelated Concept Videos
Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Hypersensitivity Reactions: Cytolytic Reactions
115
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
115

